查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518813

泌尿道感染检测市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Urinary Tract Infection Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 245 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球泌尿道感染 (UTI) 检测市场的综合报告。该报告全面评估了主要市场动态，包括驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

关键见解

  • 泌尿道感染检测市场规模（2024 年）：6.345 亿美元
  • 市场预测金额（2031 年）：9.603 亿美元
  • 全球市场成长率（2024-2031 年复合年增长率）：6.1%

泌尿道感染检测市场-研究范围：

泌尿道感染检测涉及多种诊断方法来检测是否存在引起泌尿道感染的病原体，包括尿液分析、尿液培养、聚合酶链反应（PCR）和快速试纸检测。该市场为医院、诊所、诊断实验室和家庭医疗保健机构提供服务，并提供各种测试类型，包括即时检测试剂盒和基于实验室的检测。尿路结石盛行率的增加、早期诊断意识的提高以及提高测试准确性和改善患者治疗效果的诊断技术的进步推动了市场成长。

推动市场成长的因素：

全球尿路感染检测市场是由几个关键因素推动的，例如尿路感染盛行率不断上升，特别是在女性、老年人和慢性病患者中。人们对尿路结石早期诊断和治疗重要性的认识不断提高，进一步推动了市场的扩张。快速、灵敏的诊断测试等技术进步正在提高准确性并更快获得结果，从而推动市场成长。此外，现场检测的日益普及和家庭诊断服务的扩展正在为市场参与者接触更多患者群体创造新的途径。

市场限制因素：

儘管成长前景广阔，但泌尿道感染检测市场面临监管合规性、报销政策和先进诊断检测的高成本等课题。有关诊断设备的製造、销售和使用的严格法规给製造商和医疗保健提供者带来了合规负担，影响了市场进入障碍和营运成本。此外，尿石诊断检测的报销范围有限以及先进检测设备的高成本对市场渗透构成了课题，特别是在医疗预算有限的新兴国家。为了解决这些监管和经济障碍，行业利益相关者和政策制定者必须共同努力，以促进获得负担得起且可靠的 UTI 测试解决方案。

市场机会：

由于技术创新、人口趋势和不断发展的医疗服务模式，尿路感染检测市场呈现出巨大的成长机会。远端监控和远距医疗平台等数位健康技术的整合增加了患者获得诊断服务的机会，并提高了治疗依从性和结果。此外，分子诊断应用的扩展以及同时检测多种病原体的多重检测的开发将扩大市场范围并刺激创新。策略合作伙伴关係、研发投资以及推出用户友好且具有成本效益的诊断解决方案对于利用新机会并保持在动态 UTI 检测市场的领先地位至关重要。

本报告解决的关键问题

  • 推动全球尿路感染检测市场成长的关键因素是什么？
  • 哪些测试类型和应用程式正在推动不同医疗机构中 UTI 测试的采用？
  • 技术进步如何改变 UTI 侦测市场的竞争格局？
  • 谁是泌尿道感染检测市场的主要参与者？ 他们保持市场地位的策略是什么？
  • 全球尿路感染检测市场有何新趋势与未来前景？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 作业
    • 主要趋势
  • 检定生命週期分析
  • 全球尿路感染检测市场：价值链
    • 测试套件供应商列表
    • 製造商列表
    • 销售代理商名单
    • 使用列表
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 全球 GDP 成长前景
    • 全球母公司市场概览
  • 预测因子 - 相关性和影响
  • 法规与检测试剂盒情况

第三章全球泌尿道感染检测市场展望：实际结果（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场容量（单位）预测
    • 市场规模及年成长率
    • 绝对数量的机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2019-2023 年
    • 目前市场规模预测（2024-2031 年）
  • 全球尿路感染检测市场前景：检测
    • 简介/主要发现
    • 2019-2023 年历史市场规模（百万美元）和交易量（单位）的测试分析
    • 透过测试预测 2024-2031 年当前市场规模（百万美元）和销售量（单位）
  • 市场吸引力分析：检查
  • 全球尿路感染检测市场前景：检测试剂盒
    • 简介/主要发现
    • 2019-2023 年依测试套件划分的历史市场规模（百万美元）和数量（单位）分析
    • 2024-2031 年依测试套件划分的当前市场规模（百万美元）和销售量（单位）预测
  • 市场吸引力分析：测试套件
  • 全球泌尿道感染检测市场前景：适应症
    • 简介/主要发现
    • 2019-2023 年依适应症划分的历史市场规模（百万美元）和交易量（单位）分析
    • 2024-2031 年依适应症划分的当前市场规模（百万美元）和销售（单位）预测
  • 市场吸引力分析：指标
  • 全球尿路感染检测市场展望：最终应用
    • 简介/主要发现
    • 2019-2023 年依最终用途划分的历史市场规模（百万美元）和数量（单位）分析
    • 2024-2031 年依最终用途划分的当前市场规模（百万美元）和销售（单位）预测
  • 市场吸引力分析：最终用途

第 4 章全球尿路感染检测市场展望：地区

  • 主要亮点
  • 2019-2023 年依地区历史市场规模（百万美元）及销售量（单位）分析
  • 2024-2031 年依地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：地区

第五章北美泌尿道感染检测市场展望：实际结果（2019-2023）与预测（2024-2031）

第六章欧洲泌尿道感染检测市场前景：实际结果（2019-2023）与预测（2024-2031）

第七章东亚泌尿道感染检测市场展望：实际（2019-2023）与预测（2024-2031）

第8章南亚/大洋洲泌尿道感染检测市场前景：实际结果（2019-2023年）与预测（2024-2031年）

第 9 章拉丁美洲泌尿道感染检测市场展望：实际（2019-2023 年）与预测（2024-2031 年）

第10章中东和非洲泌尿道感染检测市场展望：实际（2019-2023年）和预测（2024-2031年）

第十一章竞争态势

  • 2024 年市占率分析
  • 市场结构
    • 竞争强度图：依市场划分
    • 竞争对手仪表板
    • 外观检验能力
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • ACON Laboratories Inc.
    • Cardinal Health Inc.
    • Danaher Corporation
    • SYSMEX CORPORATION
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • Roche AG
    • LabCorp（Laboratory Corporation of America Holdings）.
    • Stryker Corporation
    • Thermo Fisher Scientific, Inc.

第12章附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP33921

Persistence Market Research has recently released a comprehensive report on the worldwide market for urinary tract infection (UTI) testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • UTI Testing Market Size (2024E): USD 634.5 Mn
  • Projected Market Value (2031F): USD 960.3 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.1%

UTI Testing Market - Report Scope:

Urinary tract infection testing encompasses a variety of diagnostic methods, including urinalysis, urine culture, polymerase chain reaction (PCR), and rapid dipstick tests, to detect the presence of pathogens causing UTIs. The market caters to hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of test types, including point-of-care testing kits and laboratory-based assays. Market growth is driven by the increasing prevalence of UTIs, rising awareness about early diagnosis, and advancements in diagnostic technologies, enhancing test accuracy and patient outcomes.

Market Growth Drivers:

The global UTI testing market is propelled by several key factors, including the growing incidence of urinary tract infections, particularly among women, the elderly, and individuals with chronic conditions. Rising awareness about the importance of early diagnosis and treatment of UTIs further drives market expansion. Technological advancements, such as the development of rapid and highly sensitive diagnostic tests, offer improved accuracy and quicker results, fostering market growth. Moreover, the increasing adoption of point-of-care testing and the expansion of home-based diagnostic services create new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the UTI testing market faces challenges related to regulatory compliance, reimbursement policies, and the high cost of advanced diagnostic tests. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for UTI diagnostic tests and the high cost of advanced testing equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to affordable and reliable UTI testing solutions.

Market Opportunities:

The UTI testing market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of molecular diagnostics and the development of multiplex assays for simultaneous detection of multiple pathogens broaden the market scope and stimulate innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic UTI testing landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the UTI testing market globally?
  • Which test types and applications are driving UTI testing adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the UTI testing market?
  • Who are the key players contributing to the UTI testing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global UTI testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global UTI testing market, including Siemens Healthineers, Abbott Laboratories, and Becton, Dickinson and Company (BD), focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular tests and rapid testing kits, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving UTI testing landscape.

Key Companies Profiled:

  • ACON Laboratories Inc.
  • Cardinal Health Inc.
  • Danaher Corporation
  • SYSMEX CORPORATION
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Roche AG
  • LabCorp (Laboratory Corporation of America Holdings).
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc.

Urinary Tract Infection Testing Market Research Segmentation

By Tests:

  • Urinalysis
  • Urine Cultures
  • Susceptibility Testing

By Tests Kits:

  • Home Test Kits
  • Laboratory Test Kits

By Indication:

  • Cystitis
  • Urethritis
  • Pyelonephritis

By End User:

  • Hospitals
  • Nephropathy Clinics
  • Diagnostic Laboratories

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Urinary Tract Infection Testing Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Tests Lifecycle Analysis
  • 2.4. Global Urinary Tract Infection Testing Market: Value Chain
    • 2.4.1. List of Tests Kits Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Tests Kits Landscape

3. Global Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn ) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019-2023
    • 3.2.2. Current Market Size Forecast, 2024-2031
  • 3.3. Global Urinary Tract Infection Testing Market Outlook: Tests
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests, 2019-2023
    • 3.3.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
      • 3.3.3.1. Urinalysis
      • 3.3.3.2. Urine Cultures
      • 3.3.3.3. Susceptibility Testing
  • 3.4. Market Attractiveness Analysis: Tests
  • 3.5. Global Urinary Tract Infection Testing Market Outlook: Tests Kits
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Tests Kits, 2019-2023
    • 3.5.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
      • 3.5.3.1. Home Test Kits
      • 3.5.3.2. Laboratory Test Kits
  • 3.6. Market Attractiveness Analysis: Tests Kits
  • 3.7. Global Urinary Tract Infection Testing Market Outlook: Indication
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Indication, 2019-2023
    • 3.7.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
      • 3.7.3.1. Cystitis
      • 3.7.3.2. Urethritis
      • 3.7.3.3. Pyelonephritis
  • 3.8. Market Attractiveness Analysis: Indication
  • 3.9. Global Urinary Tract Infection Testing Market Outlook: End Use
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By End Use, 2019-2023
    • 3.9.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
      • 3.9.3.1. Hospitals
      • 3.9.3.2. Nephropathy Clinics
      • 3.9.3.3. Diagnostic Laboratories
      • 3.9.3.4. others
  • 3.10. Market Attractiveness Analysis: End Use

4. Global Urinary Tract Infection Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Region, 2019-2023
  • 4.3. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Region, 2024-2031
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 5.3.1. By Country
    • 5.3.2. By Tests
    • 5.3.3. By Tests Kits
    • 5.3.4. By Indication
    • 5.3.5. By End Use
  • 5.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 5.5.1. Urinalysis
    • 5.5.2. Urine Cultures
    • 5.5.3. Susceptibility Testing
  • 5.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 5.6.1. Home Test Kits
    • 5.6.2. Laboratory Test Kits
  • 5.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 5.7.1. Cystitis
    • 5.7.2. Urethritis
    • 5.7.3. Pyelonephritis
  • 5.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 5.8.1. Hospitals
    • 5.8.2. Nephropathy Clinics
    • 5.8.3. Diagnostic Laboratories
    • 5.8.4. others
  • 5.9. Market Attractiveness Analysis

6. Europe Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Tests
    • 6.3.3. By Tests Kits
    • 6.3.4. By Indication
    • 6.3.5. By End Use
  • 6.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 6.5.1. Urinalysis
    • 6.5.2. Urine Cultures
    • 6.5.3. Susceptibility Testing
  • 6.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 6.6.1. Home Test Kits
    • 6.6.2. Laboratory Test Kits
  • 6.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 6.7.1. Cystitis
    • 6.7.2. Urethritis
    • 6.7.3. Pyelonephritis
  • 6.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 6.8.1. Hospitals
    • 6.8.2. Nephropathy Clinics
    • 6.8.3. Diagnostic Laboratories
    • 6.8.4. others
  • 6.9. Market Attractiveness Analysis

7. East Asia Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Tests
    • 7.3.3. By Tests Kits
    • 7.3.4. By Indication
    • 7.3.5. By End Use
  • 7.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 7.5.1. Urinalysis
    • 7.5.2. Urine Cultures
    • 7.5.3. Susceptibility Testing
  • 7.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 7.6.1. Home Test Kits
    • 7.6.2. Laboratory Test Kits
  • 7.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 7.7.1. Cystitis
    • 7.7.2. Urethritis
    • 7.7.3. Pyelonephritis
  • 7.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 7.8.1. Hospitals
    • 7.8.2. Nephropathy Clinics
    • 7.8.3. Diagnostic Laboratories
    • 7.8.4. others
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Tests
    • 8.3.3. By Tests Kits
    • 8.3.4. By Indication
    • 8.3.5. By End Use
  • 8.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 8.5.1. Urinalysis
    • 8.5.2. Urine Cultures
    • 8.5.3. Susceptibility Testing
  • 8.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 8.6.1. Home Test Kits
    • 8.6.2. Laboratory Test Kits
  • 8.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 8.7.1. Cystitis
    • 8.7.2. Urethritis
    • 8.7.3. Pyelonephritis
  • 8.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 8.8.1. Hospitals
    • 8.8.2. Nephropathy Clinics
    • 8.8.3. Diagnostic Laboratories
    • 8.8.4. others
  • 8.9. Market Attractiveness Analysis

9. Latin America Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Tests
    • 9.3.3. By Tests Kits
    • 9.3.4. By Indication
    • 9.3.5. By End Use
  • 9.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 9.5.1. Urinalysis
    • 9.5.2. Urine Cultures
    • 9.5.3. Susceptibility Testing
  • 9.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 9.6.1. Home Test Kits
    • 9.6.2. Laboratory Test Kits
  • 9.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 9.7.1. Cystitis
    • 9.7.2. Urethritis
    • 9.7.3. Pyelonephritis
  • 9.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 9.8.1. Hospitals
    • 9.8.2. Nephropathy Clinics
    • 9.8.3. Diagnostic Laboratories
    • 9.8.4. others
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Urinary Tract Infection Testing Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn ) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Tests
    • 10.3.3. By Tests Kits
    • 10.3.4. By Indication
    • 10.3.5. By End Use
  • 10.4. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Country, 2024-2031
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests, 2024-2031
    • 10.5.1. Urinalysis
    • 10.5.2. Urine Cultures
    • 10.5.3. Susceptibility Testing
  • 10.6. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Tests Kits, 2024-2031
    • 10.6.1. Home Test Kits
    • 10.6.2. Laboratory Test Kits
  • 10.7. Current Market Size (US$ Mn ) and Volume (Units) Forecast By Indication, 2024-2031
    • 10.7.1. Cystitis
    • 10.7.2. Urethritis
    • 10.7.3. Pyelonephritis
  • 10.8. Current Market Size (US$ Mn ) and Volume (Units) Forecast By End Use, 2024-2031
    • 10.8.1. Hospitals
    • 10.8.2. Nephropathy Clinics
    • 10.8.3. Diagnostic Laboratories
    • 10.8.4. others
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Tests Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. ACON Laboratories Inc.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Tests
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Cardinal Health Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Tests
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Danaher Corporation
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Tests
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. SYSMEX CORPORATION
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Tests
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Abbott Laboratories
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Tests
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Bio-Rad Laboratories
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Tests
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Roche AG
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Tests
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. LabCorp (Laboratory Corporation of America Holdings).
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Tests
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Stryker Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Tests
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Thermo Fisher Scientific, Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Tests
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations